Total Funding
17
47
Total FundingSeries B raised
Growth Score
-36 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
104770
A New Approach to Treating Global Infectious Diseases
- Shalabh Gupta: Founder, President & CEOPast Role: Genentech, Commercial Strategist
- Vijay Pande: Co-FounderPast Role: Folding@home, Founder
About the Company
Globavir was founded in 2011 by Dr. Shalabh Gupta. Globavir was built on multiple licenses from Stanford University from multiple different professors and multiple different departments.
In 2014, Globavir acquired BioCycive in all stock deal, and BioCycive became a wholly owned subsidiary of Globavir. In 2015, BioCycive's lead program was
partnered with Sorrento Therapeutics.
In 2016, Globavir partnered its diagnostic test with Bio-Rad.
